Sampling Protocol Sample Clauses

Sampling Protocol. Washington State Department of Ecology Environmental Assessment Program Standard Operating Procedures for Sampling of Pesticides in Surface Waters Version 2.1 Revised: Xxxx X. Xxxxxxxx Date: December 19, 2011 Reviewer : Xxxxx Xxxxxxxx Date: December 21, 2011 Author - Xxxx Xxxxxxxx Date - August 18, 2006 QA Approval Xxxxxxx X. Xxxxxx, Ecology Quality Assurance Officer Date - February 8, 2012 EAP003 APPROVED: February 8, 2012 Signatures on File Please note that the Washington State Department of Ecology’s Standard Operating Procedures (SOPs) are adapted from published methods, or developed by in-house technical and administrative experts. Their primary purpose is for internal Ecology use, although sampling and administrative SOPs may have a wider utility. Our SOPs do not supplant official published methods. Distribution of these SOPs does not constitute an endorsement of a particular procedure or method. Any reference to specific equipment, manufacturer, or supplies is for descriptive purposes only and does not constitute an endorsement of a particular product or service by the author or by the Department of Ecology. Although Ecology follows the SOP in most instances, there may be instances in which Ecology uses an alternative methodology, procedure, or process. SOP Revision History Revision Date Rev number Summary of changes Sections Reviser(s)
AutoNDA by SimpleDocs
Sampling Protocol a. All stands within a strata must use the same prism throughout strata, no exceptions. Strata StrataOrder PlotType PlotSize PPN_UT_15-19 1 BAF 20 PPN_TH_15-19 2 BAF 10 PPN_UT_20-24 3 BAF 20 PPN_TH_20-24 4 BAF 15 PPN_UT_25+ 5 BAF 20 PPN_TH_25+ 6 BAF 15 NPN_20+ 7 BAF 15 NHD_20+ 8 BAF 15 • DBH
Sampling Protocol. Sampling for FY2022–2023 will include; 1) six and one half removal passes conducted in the Grand Valley reaches, 2) two removal passes from the 25-mile reach between Loma boat landing to the Westwater BLM ranger station, UT, 3) four walleye removal passes conducted from Cisco to Potash, UT, 4) CPW will complete all work upstream of Beavertail Mountain with scope of work 126(b). Due to Program budget limits in 2020 and 2021, FWS GJ will not be conducting streamside gravel pit pond non-native fish removal. We hope to start again beginning in 2024.
Sampling Protocol. Subject to Article 8.2, annual bibliographic sampling will be conducted in accordance with this Article 8 to assist CANCOPY in allocating remuneration to its Affiliates, provided that:
Sampling Protocol. Sampling for FY2020-2021 will include; 1) eight removal passes conducted in the Grand Valley reaches, 2) two removal passes from the 25-mile reach between Loma boat landing to the Westwater BLM ranger station, UT, 3) four walleye removal passes conducted from Cisco to Potash, UT, 4) one month’s removal from streamside gravel pit ponds in the Grand Valley, and 5) CPW will complete all work upstream of Beavertail Mountain with scope of work 126(b). The UCRRP 2019-2020 non-native workshop conclusions could change these protocols.

Related to Sampling Protocol

  • Protocol No action to coerce or censor or penalize any negotiation participant shall be made or implied by any other member as a result of participation in the negotiation process.

  • Sampling The Licensee agrees that the Composition is purchased as a “Work Made for Hire” whereby the clearing of any sampled materials is the responsibility of Licensee.

  • Testing Landlord shall have the right to conduct annual tests of the Premises to determine whether any contamination of the Premises or the Project has occurred as a result of Tenant’s use. Tenant shall be required to pay the cost of such annual test of the Premises; provided, however, that if Tenant conducts its own tests of the Premises using third party contractors and test procedures acceptable to Landlord which tests are certified to Landlord, Landlord shall accept such tests in lieu of the annual tests to be paid for by Tenant. In addition, at any time, and from time to time, prior to the expiration or earlier termination of the Term, Landlord shall have the right to conduct appropriate tests of the Premises and the Project to determine if contamination has occurred as a result of Tenant’s use of the Premises. In connection with such testing, upon the request of Landlord, Tenant shall deliver to Landlord or its consultant such non-proprietary information concerning the use of Hazardous Materials in or about the Premises by Tenant or any Tenant Party. If contamination has occurred for which Tenant is liable under this Section 30, Tenant shall pay all costs to conduct such tests. If no such contamination is found, Landlord shall pay the costs of such tests (which shall not constitute an Operating Expense). Landlord shall provide Tenant with a copy of all third party, non-confidential reports and tests of the Premises made by or on behalf of Landlord during the Term without representation or warranty and subject to a confidentiality agreement. Tenant shall, at its sole cost and expense, promptly and satisfactorily remediate any environmental conditions identified by such testing in accordance with all Environmental Requirements. Landlord’s receipt of or satisfaction with any environmental assessment in no way waives any rights which Landlord may have against Tenant.

  • Quality Specifications SANMINA-SCI shall comply with the quality specifications set forth in its Quality Manual, incorporated by reference herein, a copy of which is available from SANMINA-SCI upon request.

  • Review of Materials During the term of this Agreement, Client shall ensure that all prospectuses, statements of additional information, registration statements, proxy statements, reports to shareholders, advertising and sales literature or other materials prepared for distribution to Fund shareholders or the public, which refer to the Subadviser in any way, prepared by employees or agents of Client or its affiliates are consistent with information previously provided by Subadviser. Subadviser shall promptly notify the Client of any changes to information pertaining to the Subadviser and stated in the materials described in this Section 6(g).

  • Studies The clinical, pre-clinical and other studies and tests conducted by or on behalf of or sponsored by the Company or its subsidiaries that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus were and, if still pending, are being conducted in accordance in all material respects with all statutes, laws, rules and regulations, as applicable (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA). The descriptions of the results of such studies and tests that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus are accurate and complete in all material respects and fairly present the published data derived from such studies and tests, and each of the Company and its subsidiaries has no knowledge of other studies or tests the results of which are materially inconsistent with or otherwise call into question the results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, neither the Company nor its subsidiaries has received any notices or other correspondence from the FDA or any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA with respect to any ongoing clinical or pre-clinical studies or tests requiring the termination or suspension of such studies or tests. For the avoidance of doubt, the Company makes no representation or warranty that the results of any studies, tests or preclinical or clinical trials conducted by or on behalf of the Company will be sufficient to obtain governmental approval from the FDA or any foreign, state or local governmental body exercising comparable authority.

  • Tests 7.7.1 If the Contract Documents, laws, ordinances, rules, regulations or orders of any public authority having jurisdiction require any portion of the Work to be inspected, tested or approved, the Contractor shall give the Architect timely notice of its readiness so the Architect may observe such inspection, testing or approval. The Contractor shall bear all costs of such inspections, tests or approvals conducted by public authorities.

  • Technical Specifications The Technical Specifications furnished on the CD are intended to establish the standards for quality, performance and technical requirements for all labor, workmanship, material, methods and equipment necessary to complete the Work. When specifications and drawings are provided or referenced by the County, these are to be considered part of the Scope of Work, and to be specifically documented in the Detailed Scope of Work. For convenience, the County supplied specifications, if any, and the Technical Specifications furnished on the CD.

  • Product Specifications The Company agrees that all Products sold to Xxxx hereunder shall conform to the respective specifications set forth on Schedule A or to such other specifications as are from time to time agreed upon by the Parties.

  • Periodic Review of Costs of Environmental Compliance In the ordinary course of its business, the Company conducts a periodic review of the effect of Environmental Laws on the business, operations and properties of the Company and its subsidiaries, in the course of which it identifies and evaluates associated costs and liabilities (including, without limitation, any capital or operating expenditures required for clean-up, closure of properties or compliance with Environmental Laws or any permit, license or approval, any related constraints on operating activities and any potential liabilities to third parties). On the basis of such review and the amount of its established reserves, the Company has reasonably concluded that such associated costs and liabilities would not, individually or in the aggregate, result in a Material Adverse Change.

Time is Money Join Law Insider Premium to draft better contracts faster.